rabbit anti glut3 polyclonal antibody (Biorbyt)
Structured Review

Rabbit Anti Glut3 Polyclonal Antibody, supplied by Biorbyt, used in various techniques. Bioz Stars score: 93/100, based on 6 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/rabbit+anti+glut3+polyclonal+antibody/GLUT3+antibody/pmc10143906-96-7-11
Average 93 stars, based on 6 article reviews
Images
1) Product Images from "Expression of Glucose Transporters 1 and 3 in the Placenta of Pregnant Women with Gestational Diabetes Mellitus"
Article Title: Expression of Glucose Transporters 1 and 3 in the Placenta of Pregnant Women with Gestational Diabetes Mellitus
Journal: Life
doi: 10.3390/life13040993
Figure Legend Snippet: mRNA expression of GLUT1 ( A ) and GLUT3 ( B ). The results show that there was no significant difference between the placentas of pregnant women with gestational diabetes mellitus (GDM) and those of healthy pregnant women.
Techniques Used: Expressing
Figure Legend Snippet: Protein expression of GLUT1 ( A ) and GLUT3 ( B ) on chorionic villi of the placenta. The results showed a significant increase in the protein expressions of GLUT1 and GLUT 3 in the placentas of pregnant women with GDM compared to the corresponding values in the placentas of healthy pregnant women. (*) p ≤ 0.05. (**) p ≤ 0.01.
Techniques Used: Expressing
Figure Legend Snippet: Results of immunohistochemical (IHC) staining of GLUT1 and GLUT3 in placenta sections. ( A , B ) IHC images of placenta sections, scale bar 20 µm (-ve control: without primary antibodies). ( a , b ) Statistical analysis of IHC results. The results demonstrated that the GLUT1 and GLUT3 were significantly increased in the placentas of pregnant women with GDM compared to healthy pregnant women (***) p ≤ 0.001.
Techniques Used: Immunohistochemical staining, Immunohistochemistry, Control
Related Articles
Expressing:Article Title: Expression of Glucose Transporters 1 and 3 in the Placenta of Pregnant Women with Gestational Diabetes Mellitus Article Snippet: Article Title: Expression of Glucose Transporters 1 and 3 in the Placenta of Pregnant Women with Gestational Diabetes Mellitus. Article Snippet: Immunohistochemical staining:Article Title: Expression of Glucose Transporters 1 and 3 in the Placenta of Pregnant Women with Gestational Diabetes Mellitus Article Snippet: Article Title: Expression of Glucose Transporters 1 and 3 in the Placenta of Pregnant Women with Gestational Diabetes Mellitus. Article Snippet: Immunohistochemistry:Article Title: Expression of Glucose Transporters 1 and 3 in the Placenta of Pregnant Women with Gestational Diabetes Mellitus Article Snippet: Article Title: Expression of Glucose Transporters 1 and 3 in the Placenta of Pregnant Women with Gestational Diabetes Mellitus. Article Snippet: Control:Article Title: Expression of Glucose Transporters 1 and 3 in the Placenta of Pregnant Women with Gestational Diabetes Mellitus Article Snippet: Article Title: Expression of Glucose Transporters 1 and 3 in the Placenta of Pregnant Women with Gestational Diabetes Mellitus. Article Snippet: |


![(A) Volcano plot derived from bulk RNA-seq data collected from PDGCs lentivirally infected with the SCR or CD97 shRNA (n = 3 biological replicates for each). Genes involved in canonical glycolysis and glucose transport are represented as large yellow points. Genes involved in the TCA cycle and OXPHOS (cytochrome oxidase subunits) are represented as large green points. CD97 is represented by an orange point. (B) The top ten enriched and depleted pathways determined by the largest fold enrichment among downregulated genes using GO PANTHER pathway enrichment analysis. Stars indicate metabolic pathways. (C) Correlation matrix from bulk RNA-seq data collected from PDGCs following knockdown or overexpression of CD97 shows high correlation between CD97 and glycolysis-related genes and anti-correlation with TCA cycle-related genes. HK2 (hexokinase 2) and SLC2A3 (glucose transporter 3 <t>[GLUT3])</t> transcripts are both included because they have been implicated in Warburg metabolism. (D) Bar graph showing decreased lactate production after knockdown of CD97 (n = 6 per PDGC; two-way ANOVA F 1,15 = 27.24, p < 0.001) and increased lactate production after CD97 overexpression in PDGCs (n = 3 per PDGC; two-way ANOVA F 1,6 = 26.07, p < 0.01). (E) Steady-state metabolomic data reveal depletion of glycolytic metabolites after knockdown of CD97 in PDGCs (PN [proneural], n = 2–3 [one replicate was removed for technical reasons]; CL [classical], n = 3). (F) Depleted (red) and enriched (green) heavy-labeled glycolytic and TCA cycle metabolites after a heavy-labeled glucose tracing experiment. (G) Representative Seahorse Cell Energy Phenotype graph showing OCR and ECAR changes before (baseline) and after (maximal) addition of mitochondrial stressors. (H and I) Bar graphs quantifying baseline and maximal ECAR (n = 6 per PDGC; baseline: two-way ANOVA F 1,10 = 14.06; **p < 0.01; maximal: two-way ANOVA F 1,10 = 17.87, p < 0.01). (J and K) Bar graphs quantifying baseline and maximal OCR (n = 6 per PDGC; baseline: two-way ANOVA F 1,10 = 2.820, p > 0.05; maximal: two-way ANOVA F 1,10 = 5.474; *p < 0.05). Error bars indicate SEM.](https://pub-med-central-images-cdn.bioz.com/pub_med_central_ids_ending_with_1603/pmc10841603/pmc10841603__nihms-1948162-f0004.jpg)
